These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3676016)

  • 41. [Treatment of sepsis-related acute renal failure].
    Zhang X
    Zhonghua Nei Ke Za Zhi; 2006 Sep; 45(9):711-3. PubMed ID: 17166441
    [No Abstract]   [Full Text] [Related]  

  • 42. Nursing management of continuous arteriovenous hemofiltration for acute renal failure.
    Palmer JC; Koorejian K; London JB; Dechert RE; Bartlett RH
    Focus Crit Care; 1986 Oct; 13(5):21-30. PubMed ID: 3639825
    [No Abstract]   [Full Text] [Related]  

  • 43. Continuous arterio-venous hemofiltration program implementation.
    Whitson SE; Woodford D; Ricard VT
    ANNA J; 1986 Jun; 13(3):155-7. PubMed ID: 3637084
    [No Abstract]   [Full Text] [Related]  

  • 44. Advantages of continuous arteriovenous hemofiltration in the management of acute renal failure.
    Matthaei D; Kramer P; Grieben K; Schrader J; Ansorg R; Scheler F
    Contrib Nephrol; 1982; 32():175-80. PubMed ID: 7128155
    [No Abstract]   [Full Text] [Related]  

  • 45. Diagnostic and therapeutic technology assessment. Continuous arteriovenous hemofiltration.
    JAMA; 1985 Mar; 253(9):1325-6. PubMed ID: 4046106
    [No Abstract]   [Full Text] [Related]  

  • 46. Nutrition for acute renal failure patients on continuous hemofiltration.
    Goldstein DJ
    Nutr Clin Pract; 1988 Dec; 3(6):238-41. PubMed ID: 3145400
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
    Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
    Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous arteriovenous hemofiltration--really an easy treatment?
    Sieberth HG; Mann H; Maurin N; Stiller S
    Contrib Nephrol; 1985; 44():248-59. PubMed ID: 3987289
    [No Abstract]   [Full Text] [Related]  

  • 49. Slow continuous ultrafiltration: a means of unmasking myocardial functional reserve in end-stage cardiac disease.
    Canaud B; Cristol JP; Klouche K; Béraud JJ; Du Cailar G; Ferrière M; Grolleau R; Mion C
    Contrib Nephrol; 1991; 93():79-85. PubMed ID: 1802607
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis.
    Fleming F; Bohn D; Edwards H; Cox P; Geary D; McCrindle BW; Williams WG
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):322-31. PubMed ID: 7853885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abortion and renal failure.
    Isaac V; Hemalatha H
    J Obstet Gynaecol India; 1976 Oct; 26(5):657-61. PubMed ID: 1021480
    [No Abstract]   [Full Text] [Related]  

  • 52. Comment: vancomycin and tobramycin continuous hemofiltration clearance methodologies.
    Mueller BA; Clark WR; Kraus MA; Macias WL
    Ann Pharmacother; 1993 Oct; 27(10):1285-6. PubMed ID: 8123119
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Continuous hemofiltration in the treatment of children's acute renal failure].
    Chang P; Tao SH; Hu YQ; Li J; Feng Z
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):949-50. PubMed ID: 15733376
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of early and intensive continuous venovenous hemofiltration on patients with cardiogenic shock and acute kidney injury after cardiac surgery.
    Li SY; Yang WC; Chuang CL
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1628-33. PubMed ID: 24929801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late initiation of continuous veno-venous hemofiltration therapy is associated with a lower survival rate in surgical critically ill patients with postoperative acute kidney injury.
    Wu SC; Fu CY; Lin HH; Chen RJ; Hsieh CH; Wang YC; Yeh CC; Huang HC; Huang JC; Chang YJ
    Am Surg; 2012 Feb; 78(2):235-42. PubMed ID: 22369836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL6 plasma concentrations in patients with sepsis receiving SLED and antibiotics: a predictor for survival.
    McGuire TR; Reardon NT; Bogard K; Plumb TJ; Bultsma CJ; Nissen SW; Fuller PD; Olsen KM
    In Vivo; 2014; 28(6):1131-4. PubMed ID: 25398811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemofiltration in children.
    Saborio P; Hahn S; Scheinman JI; Chan JC
    Int J Artif Organs; 1998 Jul; 21(7):371-7. PubMed ID: 9745990
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
    Gu Q; Zhu ZH; Ge M; Ge WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.